GENEVA--(BUSINESS WIRE)--Acrongenomics, Inc. (OTCBB:AGNM) and Molecular Vision, Ltd (MVL). -- an Imperial Innovations spin-out company are pleased to announce today that due to the rapid progress of research and development, the BioLED Technology Platform has been rapidly adapted for chemiluminescence and fluorescence detection.
